Publications found:
108
Sort by:
Alopecia Disease - Global Clinical Trials Review, H1, 2021
US$ 2,500.00
Alopecia Disease - Global Clinical Trials Review, H1, 2021 GlobalData's clinical trial report, “Alopecia Disease - Global Clinical Trials Review, H1, 2021' provides an overview of Alopecia Clinical...
January 2021
318 pages
Fatigue Disease - Global Clinical Trials Review, H1, 2021
US$ 2,500.00
Fatigue Disease - Global Clinical Trials Review, H1, 2021 GlobalData's clinical trial report, “Fatigue Disease - Global Clinical Trials Review, H1, 2021' provides an overview of Fatigue Clinical tri...
January 2021
392 pages
Fabry Disease - Global Clinical Trials Review, H1, 2021
US$ 2,500.00
Fabry Disease - Global Clinical Trials Review, H1, 2021 GlobalData's clinical trial report, “Fabry Disease - Global Clinical Trials Review, H1, 2021' provides an overview of Fabry Disease Clinical t...
January 2021
115 pages
Sezary Syndrome - Global Clinical Trials Review, H1, 2021
US$ 2,500.00
Sezary Syndrome - Global Clinical Trials Review, H1, 2021 GlobalData's clinical trial report, “Sezary Syndrome - Global Clinical Trials Review, H1, 2021' provides an overview of Sezary Syndrome Clin...
January 2021
165 pages
Contract Research Organizations (CRO) Market by Services (Clinical Research [Phase II, Phase III], Pre-Clinical [Pharmacokinetics, Toxicology], Laboratory Services, and others), Therapeutic Area, End, and Geography - Global Forecast to 2027
US$ 4,175.00
Contract Research Organizations (CRO) Market by Services (Clinical Research [Phase II, Phase III], Pre-Clinical [Pharmacokinetics, Toxicology], Laboratory Services, and others), Therapeutic Area, End,...
January 2021
240 pages
Coronavirus Disease 2019 (COVID-19) Impact on Novavax Inc.
US$ 495.00
Coronavirus Disease 2019 (COVID-19) Impact on Novavax Inc. SUMMARY Novavax is a late-stage clinical biotechnology company with a recombinant subunit innovative vaccine platform and an adjuvant platf...
December 2020
29 pages
Active Pharmaceutical Ingredients: Global Markets
US$ 5,500.00
... (Active Pharmaceutical Ingredients: Global Markets to 2022) covers an overview of the pharmaceutical industry landscape and active pharmaceutical ingredients (API), along with the current trends and dynamics shaping the API market landscape. API sourcing ...
December 2020
148 pages
Burns Disease - Global Clinical Trials Review, H2, 2020
US$ 2,500.00
Burns Disease - Global Clinical Trials Review, H2, 2020 SUMMARY GlobalData's clinical trial report, “Burns Disease - Global Clinical Trials Review, H2, 2020' provides an overview of Burns Clinical t...
December 2020
291 pages
Delirium Disease - Global Clinical Trials Review, H2, 2020
US$ 2,500.00
Delirium Disease - Global Clinical Trials Review, H2, 2020 SUMMARY GlobalData's clinical trial report, “Delirium Disease - Global Clinical Trials Review, H2, 2020' provides an overview of Delirium C...
December 2020
296 pages
Tetanus Disease - Global Clinical Trials Review, H2, 2020
US$ 2,500.00
Tetanus Disease - Global Clinical Trials Review, H2, 2020 SUMMARY GlobalData's clinical trial report, “Tetanus Disease - Global Clinical Trials Review, H2, 2020' provides an overview of Tetanus Clin...
December 2020
276 pages